Literature DB >> 27061883

Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement.

Michela Buglione1, Roberta Cavagnini2, Federico Di Rosario3, Marta Maddalo4, Lucia Vassalli5, Salvatore Grisanti6, Stefano Salgarello7, Ester Orlandi8, Paolo Bossi9, Alessandra Majorana10, Giorgio Gastaldi11, Alfredo Berruti12, Fabio Trippa13, Pietro Nicolai14, Andrei Barasch15, Elvio G Russi16, Judith Raber-Durlacher17, Barbara Murphy18, Stefano M Magrini19.   

Abstract

Radiotherapy alone or in combination with chemotherapy and/or surgery is a well-known radical treatment for head and neck cancer patients. Nevertheless acute side effects (such as moist desquamation, skin erythema, loss of taste, mucositis etc.) and in particular late toxicities (osteoradionecrosis, xerostomia, trismus, radiation caries etc.) are often debilitating and underestimated. A multidisciplinary group of head and neck cancer specialists from Italy met in Milan with the aim of reaching a consensus on a clinical definition and management of these toxicities. The Delphi Appropriateness method was used for this consensus and external experts evaluated the conclusions. The paper contains 20 clusters of statements about the clinical definition and management of stomatological issues that reached consensus, and offers a review of the literature about these topics. The review was split into two parts: the first part dealt with dental pathologies and osteo-radionecrosis (10 clusters of statements), whereas this second part deals with trismus and xerostomia (10 clusters of statements).
Copyright © 2016. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Chemotherapy; Head and neck cancer; Radio-induced trismus; Radio-induced xerostomia; Radiotherapy; Trismus; Xerostomia

Mesh:

Substances:

Year:  2016        PMID: 27061883     DOI: 10.1016/j.critrevonc.2016.03.012

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  24 in total

1.  The Chicken or the Egg? Changes in Oral Microbiota as Cause or Consequence of Mucositis During Radiation Therapy.

Authors:  Stephen T Sonis
Journal:  EBioMedicine       Date:  2017-03-11       Impact factor: 8.143

2.  Priorities of human papillomavirus-associated oropharyngeal cancer patients at diagnosis and after treatment.

Authors:  Melina J Windon; Carole Fakhry; Farhoud Faraji; Tanya Troy; Christine G Gourin; Ana P Kiess; Wayne Koch; David W Eisele; Gypsyamber D'Souza
Journal:  Oral Oncol       Date:  2019-06-04       Impact factor: 5.337

3.  Incorporating Multiple Perspectives Into the Development of an Electronic Survivorship Platform for Head and Neck Cancer.

Authors:  Talya Salz; Rebecca B Schnall; Mary S McCabe; Kevin C Oeffinger; Stacie Corcoran; Andrew J Vickers; Andrew L Salner; Ellen Dornelas; Nirupa J Raghunathan; Elizabeth Fortier; Janet McKiernan; David J Finitsis; Susan Chimonas; Shrujal Baxi
Journal:  JCO Clin Cancer Inform       Date:  2018-12

Review 4.  Radiation-Induced Tissue Damage: Clinical Consequences and Current Treatment Options.

Authors:  Hillary Nepon; Tyler Safran; Edward M Reece; Amanda M Murphy; Joshua Vorstenbosch; Peter G Davison
Journal:  Semin Plast Surg       Date:  2021-09-10       Impact factor: 2.195

5.  Effectiveness of tapentadol prolonged release for the management of painful mucositis in head and neck cancers during intensity modulated radiation therapy.

Authors:  Mazzola Rosario; Ricchetti Francesco; Fersino Sergio; Giaj Levra Niccolò; Fiorentino Alba; Nicodemo Maurizio; Albanese Sergio; Gori Stefania; Alongi Filippo
Journal:  Support Care Cancer       Date:  2016-07-22       Impact factor: 3.603

6.  Oral complications at 6 months after radiation therapy for head and neck cancer.

Authors:  R V Lalla; N Treister; T Sollecito; B Schmidt; L L Patton; K Mohammadi; J S Hodges; M T Brennan
Journal:  Oral Dis       Date:  2017-08-03       Impact factor: 3.511

7.  Prosthetic management of patients with oro-maxillo-facial defects: a long-term follow-up retrospective study.

Authors:  G Gastaldi; L Palumbo; C Moreschi; E F Gherlone; P Capparé
Journal:  Oral Implantol (Rome)       Date:  2017-11-30

8.  Evaluation of the correlation between side effects to oral mucosa, salivary glands, and general health status with quality of life during intensity-modulated radiotherapy for head and neck cancer.

Authors:  Marina Kimie Oba; Lara Maria Alencar Ramos Innocentini; Gustavo Viani; Hilton Marcos Alves Ricz; Thiago de Carvalho Reis; Tatiane Cristina Ferrari; Leandro Dorigan de Macedo
Journal:  Support Care Cancer       Date:  2020-04-21       Impact factor: 3.603

Review 9.  Pharmacological interventions for preventing dry mouth and salivary gland dysfunction following radiotherapy.

Authors:  Philip Riley; Anne-Marie Glenny; Fang Hua; Helen V Worthington
Journal:  Cochrane Database Syst Rev       Date:  2017-07-31

10.  The Head and Neck Survivorship Tool (HN-STAR) Trial (WF-1805CD): A protocol for a cluster-randomized, hybrid effectiveness-implementation, pragmatic trial to improve the follow-up care of head and neck cancer survivors.

Authors:  Talya Salz; Jamie S Ostroff; Chandylen L Nightingale; Thomas M Atkinson; Eleanor C Davidson; Sankeerth R Jinna; Anuja Kriplani; Glenn J Lesser; Kathleen A Lynch; Deborah K Mayer; Kevin C Oeffinger; Sujata Patil; Andrew L Salner; Kathryn E Weaver
Journal:  Contemp Clin Trials       Date:  2021-05-21       Impact factor: 2.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.